medicine for chronic lymphocytic leukemia - Page 3 of 4

CYTOMAB 500MG INJ

CYTOMAB 500MG INJ is a Schedule H drug. CYTOMAB 500MG INJ is composed of: RITUXIMAB (500.0 MG)

REDITUX INJ is a Schedule H drug. REDITUX INJ is composed of: RITUXIMAB (10 MG/ML)

REDITUX-RA INJ is a Schedule H drug. REDITUX-RA INJ is composed of: RITUXIMAB (10 MG/ML)

MABTAS INJ is a Schedule H drug. MABTAS INJ is composed of: RITUXIMAB (10 MG/ML)

VENETOCLAX is a Schedule H drug.

RITUXIMAB is a Schedule H drug.

OFATUMUMAB is a Schedule H drug.

LYMFUDA 10MG TAB is a Schedule H drug. LYMFUDA 10MG TAB is composed of: FLUDARABINE (10.0 MG)

FLUDOCYTE 50MG INJ is a Schedule H drug. FLUDOCYTE 50MG INJ is composed of: FLUDARABINE (50.0 MG)

FLUDARA 50MG INJ is a Schedule H drug. FLUDARA 50MG INJ is composed of: FLUDARABINE (50.0 MG)